Professional Documents
Culture Documents
Name of Drug Classification of Drug Mechanism of Action Indication Contraindications Side Effects Nursing Responsibilities
Name of Drug Classification of Drug Mechanism of Action Indication Contraindications Side Effects Nursing Responsibilities
Name of Drug Classification Mechanism of Action Indication Contraindications Side Effects Nursing Responsibilities
of Drug
DRUG STUDY
Generic Name: Therapeutic: Bind to bacterial cell Treatment of Hypersensitivity to GI: Before:
Cefuroxime Anti-infectives wall membrane, It is effective for cephalosporins Diarrhea,
Determine history
causing cell death the treatment of and related nausea, antibiotic-
Trade Name: Pharmacologic: penicillinase- antibiotics; associated colitis. of hypersensitivity reacti
Ceftin Second Therapeutic Effects: producingNeisseria pregnancy
ons to cephalosporins,
generation Bactericidal action (category B), Skin:
gonorrhoea(PPNG).
Cephalosporins lactation. Ra sh , penicillins, and history
Effectively treats
pruritus, urticaria.
Pregnancy bone and joint of allergies, particularly
Catergory B infections, Urogenital: to drugs, before therapy
bronchitis, Increased serum
meningitis, creatinine and is initiated.
gonorrhea, otitis BUN, decreased Lab tests: Perform
media, creatinine
clearance. culture and sensitivity
pharyngitis/tonsilliti
s, sinusitis, lower tests before initiation of
respiratory tract Hemat:
Hemolytic anemia therapy and periodically
infections, skin and
soft tissue during therapy if
MISC:
infections, urinary Anaphylaxis indicated. Therapy may
tract infections, and
be instituted pending
is used for surgical
prophylaxis, test results. Monitor
reducing or periodically BUN and
eliminating
infection. creatinine clearance.
During:
DRUG STUDY
Inspect IM and IV
injection sites frequently
for signs of phlebitis.
Monitor for
manifestations
of hypersensitivity (see
Appendix F).
Discontinue drug and
report their appearance
promptly.
Monitor I&O rates
and pattern: Especially
important in severely ill
patients receiving high
doses. Report any
significant changes.
Report onset of loose
stools or diarrhea.
Although
pseudomembranous
colitis (see Signs &
Symptoms, Appendix F)
DRUG STUDY